{"name":"LeMaitre Vascular","slug":"lemaitre","ticker":"LMAT","exchange":"NASDAQ","domain":"lemaitre.com","description":"LeMaitre Vascular is an American medical device company established in 1986 by vascular surgeon George D. LeMaitre, and based in Burlington, Massachusetts, which provides devices, implants and human tissue cryopreservation services used by surgeons in the treatment of vascular conditions, particularly peripheral vascular disease. As of 2022, LeMaitre Vascular sells directly to hospitals in 25 countries and through distributors in more than 70 countries throughout North America, Europe and Asia/Pacific Rim.","hq":"Burlington, MA","founded":0,"employees":"646","ceo":"George W. LeMaitre","sector":"Medical Devices — Vascular Surgery","stockPrice":98.81,"stockChange":0.64,"stockChangePercent":0.65,"marketCap":"$2.3B","metrics":{"revenue":256282000,"revenueGrowth":11.2,"grossMargin":71.3,"rdSpend":14139000,"netIncome":57734000,"cash":367232992,"dividendYield":1.02,"peRatio":36.3,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"Vascutek Vascular Graft patent cliff ($10.0M at risk)","drug":"Vascutek Vascular Graft","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"LeMaitre Vascular Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"LeMaitre Vascular reported fourth quarter and full year 2023 financial results, with revenue of $44.8 million and $173.8 million, respectively.","drugName":"","sentiment":"neutral"},{"date":"2023-11-15","type":"deal","headline":"LeMaitre Vascular Announces Agreement to Acquire Vascutek","summary":"LeMaitre Vascular announced an agreement to acquire Vascutek, a leading manufacturer of vascular grafts and stent grafts.","drugName":"","sentiment":"positive"},{"date":"2023-08-01","type":"regulatory","headline":"LeMaitre Vascular Receives FDA Clearance for New Vascular Graft","summary":"LeMaitre Vascular received FDA clearance for a new vascular graft, expanding its product portfolio in the vascular surgery market.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNdHZRNzJaRE1VdnNZVnEwRnB2MHp5aklzX0xDU2ZfQ2hKQmc2RlBrUG52TWEwdVFlek85Mkstdi04czJSWVVzQ2w3aWRQVFFGNFdnYW1ZbjMwMW1HVUNZa04zWEgtTkxEdWNTVy1Ld3o2cjhUNnZCVG54OFBkdmNqZnNqbEJJaXFiZXI2enRpRXB5QXpHUGprWEFtUm92WHdzS2hz?oc=5","date":"2026-04-03","type":"regulatory","source":"Defense World","summary":"LeMaitre Vascular (NASDAQ:LMAT) Upgraded at Freedom Capital - Defense World","headline":"LeMaitre Vascular (NASDAQ:LMAT) Upgraded at Freedom Capital","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxPRUZWZUJQeEoyMDgzRUk0bG1ZREM1RHJmVXJ4LUJFcG5OVVlNZWlibFV6T3ZTWFpXNk9Mcy0xeDc2Z3ZRM3dyaVp6QzN2dGRyblBRdldLczBnaUVGWWZjVFlneTZFTnpONlJYZndieHJ4ZFM1cU1pczRoWE9kdHB2d0ctcEF3aUFMV2t2RjRzWi00ZzNhNk9HUTVqUUR6N21FakpEamRjZDFFSWp4R3pjODIxTF8telVtZ0NyR2RBbXJRWDFzM25EUmdwem1sZWVaLWVtZDVn?oc=5","date":"2026-04-02","type":"regulatory","source":"MarketBeat","summary":"SG Americas Securities LLC Raises Stock Position in LeMaitre Vascular, Inc. $LMAT - MarketBeat","headline":"SG Americas Securities LLC Raises Stock Position in LeMaitre Vascular, Inc. $LMAT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPUVE0NU8wNVFGMWIxdTJYV081aGl3QV9vcTUtRGtpcGVKdzZDZWVTSHJndTZ5Y3h6UXVtNlFIeTg4b2NzM3duRmNoOC1jNGlNT19uNm1jVXUxVkFTaWRMczR1YXg3UlhEUS1nWXZvYjRGVXJJQ25ObjBzOWxrQU4wcGw5NV9QNktEMTNGeUJLeFJVSzV5OUFib01RTjBHQTlWZDg2NWM5NFJ3RzRRQVlGWnhn?oc=5","date":"2026-03-28","type":"regulatory","source":"The Motley Fool","summary":"A LeMaitre Vascular (LMAT) Insider Sold 2,625 Shares for $285K - The Motley Fool","headline":"A LeMaitre Vascular (LMAT) Insider Sold 2,625 Shares for $285K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQeHdtN1NCT2VjT1VqenRIeTlLc0N3M01rU1pGYTVJQl9qS1FmT3VVcUxkQWI1MUcxS0JNVUxiaFNKUjljTml2dmFGTUx0UWlBcExDajd0SUszNGY4ZDM2ZXN0U3pzMWI0T3FEeE9lSl93SC1nTlpMd1RhWXVrTHoxZEIzeGYwMHpsNkw1c2d3cmk2b2VmbUpxRGM3ZWhoaGhob05nSGk5U2xmdGlHQUdrQ2R3ekEtUjZaZ0NRbW1haGxjZFdtZm1qbUhNWnZZSGpN?oc=5","date":"2026-03-10","type":"regulatory","source":"MarketBeat","summary":"First Trust Advisors LP Grows Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat","headline":"First Trust Advisors LP Grows Stock Holdings in LeMaitre Vascular, Inc. $LMAT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQSUtKM0RSNWdWZTNmQk14UFJDUjFiNGJ1bjNnSGVIZFhwNENSYTZESWhEQXZZN01ILTcwZC1td1BYSjdvMno0dEd4V09wbFpPN1hyOXdDTW5YUVgxRWxrLUFXbnh5M2c5cm1GYVRiSC1Rc0tlU2dQLVNXTjFWM1poWXl6aHNDVTlMTFhKWTBscDNHaWVCZkE?oc=5","date":"2026-02-27","type":"regulatory","source":"Seeking Alpha","summary":"LeMaitre Vascular: The Compounder Keeps Compounding (NYSE:MDT) - Seeking Alpha","headline":"LeMaitre Vascular: The Compounder Keeps Compounding (NYSE:MDT)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxNYVdaaHVUYjBBTGJwcWYzdEx6RnpKWmtrTGdZOVIzNzJPNTZTTG94a3JaeWxIRkpKZmt0X1pRSW02REdfTW5vd2VqcGJ5bEItLWdBa2djQnpzTk45aFJXZlRNQS11elVQOEhQVm9HbmlZZndjVlFHUXBxOE15anZvTWtDbDFsV2ludE1fM0U3RHpmLW0yWDJicFpDMXdKXzdvbEZ1eWFCVElDNkpTVkN2NU9XazRzOUhaOENMRGZBT3FDWHBFM0tlYWszeUx2dDJLVUV3VzlGYW05emdqZ2p0MFd0N04xTWNVUk1ZcUtwYzl2S0dkUHpDUlB5MWJRX1N5?oc=5","date":"2025-09-30","type":"pipeline","source":"FinancialContent","summary":"Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge - FinancialContent","headline":"Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOX05BWkhaRnlqbUlQaU1rcy1xOTFrNHJJU1VTWW50a0Y3YUx6Tkw0YzU5UE00MTVGVEFPRnJ0aU9iMmh4NmNUYkxRT1FoRnl6YkJXdXlaLWxrM0FHZXpLZFhmVHJHVVhlUjE3OXBlNWFxTEJJbmJDQWdSX3VrSDlBYW5MZkUwa3VXZ1VtTnBfa2d3QjlESWExNXpUVW1Jb2FaQXBfRDVkbV9QNlVwb0ZtcExkUQ?oc=5","date":"2025-09-15","type":"regulatory","source":"Seeking Alpha","summary":"LeMaitre Vascular: Investment Debate Remains In Place (NASDAQ:LMAT) - Seeking Alpha","headline":"LeMaitre Vascular: Investment Debate Remains In Place (NASDAQ:LMAT)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQYnhCd0ZGZnNyckpleXNmM294eGpBTldtVGZMS2NyLV9NaFh5Q3NTUG1vel9KeDFySDNSTHFpZWRiN0NNaVAyd3Y0RnNValNIRlF1TFhhcE5DOE9WQko0ZFZKM05rdktBejJYYzZqbm1oZ3IzRmhSV2VPWkRpTEwzYlc3Rm1lM2VKMUpQYnhiTTJyVXdGT3gtUjdKMm5wdw?oc=5","date":"2025-06-17","type":"regulatory","source":"Seeking Alpha","summary":"LeMaitre Vascular: Scaling Nicely As Global Demand Builds (NASDAQ:LMAT) - Seeking Alpha","headline":"LeMaitre Vascular: Scaling Nicely As Global Demand Builds (NASDAQ:LMAT)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxObmsxZ2NycndNZHN5M0N6QUJ4WkRzdFp2LWt6S2V5bGpaUzVUY2ljTFhYX1BJQ1oyYXpxT19mSWFncEFJa25aZEd4blFqaG5JVk1xcEhHdWdTZElCTlYtd2pIUm0tbXBValpFTGxMbG5Ob3Z0XzFhSVotUzdyVXJHZ1VBLUY5b1dqU3RJMWN6MmdTWWpjeGxIVXp4ZnN0Zw?oc=5","date":"2024-07-23","type":"regulatory","source":"Seeking Alpha","summary":"LeMaitre Vascular: A Small Cap With Best-In-Industry Growth (NASDAQ:LMAT) - Seeking Alpha","headline":"LeMaitre Vascular: A Small Cap With Best-In-Industry Growth (NASDAQ:LMAT)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTFBudFhOWG5KeWthNDVDaS1UMk5fNE5QY3h1T0FPQUh5d1hSbGdjbENPR1dkdWhiWnAxeGJnVFZ3OFpZd1h3UjFoaWszYnpVeHBBWmdvcE15TWhMcHQ3aXhMRmtxV3hFUQ?oc=5","date":"2024-05-11","type":"regulatory","source":"MarketBeat","summary":"LeMaitre Vascular (LMAT) Stock Forecast and Price Target 2026 - MarketBeat","headline":"LeMaitre Vascular (LMAT) Stock Forecast and Price Target 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE1jT1BsTEVIRTdMa18xWk1BSWFCSDQ4UWpDZ3FYMkwwS3hULWl4azFxRHFxXzhhR1VsMmhJTXNWeHZFaUY4cklLMEp4YnBTdTRT?oc=5","date":"2023-08-20","type":"pipeline","source":"CNN","summary":"symbol__ Stock Quote Price and Forecast - CNN","headline":"symbol__ Stock Quote Price and Forecast","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFBEeWtmUk82emJpbzd6ZnBIZEFlNnJ1RkpseDByaTJ2LUNXbDIzYlZiNmpER3BnT0VpTEs0SHowazh5aElhZ0ZrVG8tWmZVN3FSSkE?oc=5","date":"2017-05-07","type":"regulatory","source":"Yahoo Finance UK","summary":"LeMaitre Vascular, Inc. (LMAT) stock price, news, quote and history - Yahoo Finance UK","headline":"LeMaitre Vascular, Inc. (LMAT) stock price, news, quote and history","sentiment":"neutral"}],"patents":[{"drugName":"Vascutek Vascular Graft","drugSlug":"vascular-graft","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":10000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":3,"keyCompetitors":["Medtronic","Boston Scientific","Abbott Laboratories"],"therapeuticFocus":["Vascular Surgery"],"financials":{"source":"sec_edgar+yahoo","revenue":249602000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":249602000,"period":"2025-12-31"},{"value":219863000,"period":"2024-12-31"},{"value":219863000,"period":"2024-12-31"},{"value":193484000,"period":"2023-12-31"},{"value":193484000,"period":"2023-12-31"}],"grossProfit":178539000,"grossProfitHistory":[{"period":"2025-12-31","value":178539000},{"period":"2024-12-31","value":150901000},{"period":"2023-12-31","value":127049000},{"period":"2022-12-31","value":104896000}],"rdSpend":14139000,"rdSpendHistory":[{"period":"2025-12-31","value":14139000},{"period":"2024-12-31","value":15650000},{"period":"2023-12-31","value":16966000},{"period":"2022-12-31","value":13294000}],"sgaSpend":96488000,"operatingIncome":67912000,"operatingIncomeHistory":[{"period":"2025-12-31","value":67912000},{"period":"2024-12-31","value":52256000},{"period":"2023-12-31","value":37197000},{"period":"2022-12-31","value":29936000}],"netIncome":57734000,"netIncomeHistory":[{"period":"2025-12-31","value":57734000},{"period":"2024-12-31","value":44038000},{"period":"2023-12-31","value":30105000},{"period":"2022-12-31","value":20636000}],"eps":2.52,"epsHistory":[{"period":"2025-12-31","value":2.52},{"period":"2024-12-31","value":1.93},{"period":"2023-12-31","value":1.34},{"period":"2022-12-31","value":0.93}],"cash":28244000,"cashHistory":[{"period":"2025-12-31","value":28244000},{"period":"2024-12-31","value":25610000},{"period":"2023-12-31","value":24269000},{"period":"2022-12-31","value":19134000}],"totalAssets":615690000,"totalLiabilities":222174000,"totalDebt":185592000,"equity":393516000,"operatingCashflow":81251000,"operatingCashflowHistory":[{"period":"2025-12-31","value":81251000},{"period":"2024-12-31","value":44124000},{"period":"2023-12-31","value":36751000},{"period":"2022-12-31","value":25378000}],"capex":-6783000,"capexHistory":[{"period":"2025-12-31","value":-6783000},{"period":"2024-12-31","value":-6962000},{"period":"2023-12-31","value":-7265000},{"period":"2022-12-31","value":-3229000}],"freeCashflow":74468000,"dividendsPaid":-18109000,"buybacks":-642000,"employees":646,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":26561000,"ebit":20972000,"ebitda":23595000,"period":"2026-03-31","revenue":66551000,"epsBasic":0.69,"netIncome":15679000,"rdExpense":4060000,"epsDiluted":0.68,"grossProfit":48396000,"operatingIncome":17775000},{"sga":23825000,"ebit":21598000,"ebitda":24203000,"period":"2025-12-31","revenue":64453000,"epsBasic":0.69,"netIncome":15582000,"rdExpense":3533000,"epsDiluted":0.68,"grossProfit":46190000,"operatingIncome":18832000},{"sga":22673000,"ebit":23870000,"ebitda":26483000,"period":"2025-09-30","revenue":61046000,"epsBasic":0.77,"netIncome":17362000,"rdExpense":2970000,"epsDiluted":0.75,"grossProfit":45955000,"operatingIncome":20312000},{"sga":25291000,"ebit":19369000,"ebitda":22017000,"period":"2025-06-30","revenue":64232000,"epsBasic":0.61,"netIncome":13779000,"rdExpense":3541000,"epsDiluted":0.6,"grossProfit":44974000,"operatingIncome":16142000},{"sga":24699000,"ebit":15531000,"ebitda":18083000,"period":"2025-03-31","revenue":59871000,"epsBasic":0.49,"netIncome":11011000,"rdExpense":4095000,"epsDiluted":0.48,"grossProfit":41420000,"operatingIncome":12626000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-12-31","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":98.81,"previousClose":98.17,"fiftyTwoWeekHigh":118.01,"fiftyTwoWeekLow":78.35,"fiftyTwoWeekRange":"78.35 - 118.01","fiftyDayAverage":109.83,"twoHundredDayAverage":93.93,"beta":0.6,"enterpriseValue":2065839104,"forwardPE":30.3,"priceToBook":5.55,"priceToSales":8.81,"enterpriseToRevenue":8.06,"enterpriseToEbitda":26.23,"pegRatio":3.07,"ebitda":78750000,"ebitdaMargin":30.7,"freeCashflow":53266876,"operatingCashflow":87305000,"totalDebt":189815008,"debtToEquity":46.7,"currentRatio":14.32,"returnOnAssets":7.2,"returnOnEquity":16.5,"analystRating":"2.3 - Buy","recommendationKey":"buy","numberOfAnalysts":8,"targetMeanPrice":120.12,"targetHighPrice":135,"targetLowPrice":104,"dividendRate":1,"payoutRatio":0.31,"fiveYearAvgDividendYield":0.88,"exDividendDate":1779321600,"insiderHeldPercent":6.7,"institutionHeldPercent":98.6,"sharesOutstanding":22850739,"floatShares":21219196,"sharesShort":1162198,"shortRatio":6.62,"shortPercentOfFloat":5.1,"epsTrailing":2.72,"epsForward":3.26,"revenuePerShare":11.29,"bookValue":17.8,"officers":[{"age":60,"name":"Mr. George W. LeMaitre","title":"Chairman & CEO"},{"age":61,"name":"Mr. David B. Roberts","title":"President & Director"},{"age":54,"name":"Mr. Trent G. Kamke","title":"Senior Vice President of Operations"},{"age":91,"name":"Dr. George D. LeMaitre FACS, M.D.","title":"Founder and Chairman of Scientific Advisory Board"},{"age":54,"name":"Ms. Laurie A. Churchill J.D.","title":"Chief Legal Officer"},{"age":52,"name":"Ms. Kimberly L. Cieslak","title":"Vice President of Marketing"},{"age":43,"name":"Mr. Daniel J. Mumford","title":"Senior Director of Human Resources"},{"age":51,"name":"Mr. Jonathan W. Ngau","title":"Senior Vice President of Information Technology"}],"industry":"Medical Instruments & Supplies","irWebsite":"","website":"https://www.lemaitre.com","phone":"781 221 2266"}}